Zhang 1996 (CPZ).
Methods | Allocation: randomised. Blindness: no details. Duration: five weeks. Setting: no details. | |
Participants | Diagnosis: schizophrenia (CCMD‐2‐R). N=41. Sex: male and female. Age: mean ˜28 years. History: length of illness ˜8±7.5 years. | |
Interventions | 1. Clozapine: dose 225 to 450 mg/d. N=20. 2. Chlorpromazine: dose 400‐750 mg/d. N=21. | |
Outcomes | Leaving the study early. | |
Notes | CSG: 8366 | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Adequate sequence generation? | Unclear risk | Randomised ‐ no details |
Allocation concealment? | Unclear risk | No details |
Blinding? All outcomes | Unclear risk | No details |
Incomplete outcome data addressed? All outcomes | Low risk | No participants left the study early |
Free of selective reporting? | Unclear risk | No details |
Free of other bias? | Unclear risk | Unclear |